Zika virus

Zika virus
Name	Zika virus
Virus group	IV (ssRNA(+))
Family	Flaviviridae
Genus	Flavivirus
Species	Zika virus
Genome	~10.8 kb positive-sense RNA
Vectors	Aedes mosquitoes
Hosts	Humans, non-human primates

Zika virus

Zika virus emerged as a mosquito-borne pathogen that gained global attention after outbreaks in the Pacific and the Americas in the 2010s. It is a member of the Flavivirus genus within the family Flaviviridae, related to Dengue fever, Yellow fever, and West Nile virus. Studies of its genetic lineages, transmission dynamics, and clinical impacts have involved researchers from institutions such as the Centers for Disease Control and Prevention, World Health Organization, and universities including Harvard University and the University of São Paulo.

virology and classification

Zika virus is a positive-sense, single-stranded RNA virus in the genus Flavivirus and family Flaviviridae, with a genome organization typical of flaviviruses encoding structural proteins (C, prM, E) and nonstructural proteins (NS1–NS5). Phylogenetic analyses comparing isolates from Africa, Asia, and the Americas have been conducted by teams at the Broad Institute, Emory University, and the Pasteur Institute to resolve two major lineages: African and Asian. Structural studies using cryo-electron microscopy at facilities like the European Molecular Biology Laboratory and Max Planck Institute have elucidated the envelope protein conformation shared with West Nile virus and Dengue virus. Viral replication occurs in the cytoplasm with RNA-dependent RNA polymerase activity localized to NS5, a target investigated by laboratories at the Scripps Research Institute and Johns Hopkins University for antiviral development.

transmission and vectors

Primary transmission is via bites from infected Aedes mosquitoes, notably Aedes aegypti and Aedes albopictus, whose distributions have been mapped by researchers at the London School of Hygiene & Tropical Medicine and Monash University. Sexual transmission was documented in case reports and cohort studies involving clinicians at the Centers for Disease Control and Prevention, leading to guidance by the World Health Organization and national agencies such as the Ministry of Health (Brazil). Perinatal and in utero transmission was established during investigations by teams from the Oswaldo Cruz Foundation and Mount Sinai Health System, prompting obstetric advisories from organizations like the American College of Obstetricians and Gynecologists. Rare reports implicated blood transfusion as a route, investigated by blood safety groups at the American Red Cross and European Centre for Disease Prevention and Control.

clinical manifestations and complications

Acute infection commonly causes a mild, self-limited illness characterized by fever, rash, arthralgia, and conjunctivitis, described in clinical series from clinics affiliated with University of Puerto Rico, Instituto Nacional de Infectologia Evandro Chagas, and Centers for Disease Control and Prevention. A major complication is congenital infection resulting in microcephaly and a spectrum of brain anomalies, identified in epidemiological and case-control studies led by researchers at Fiocruz, Columbia University, and the Pan American Health Organization. Neurological complications in adults include Guillain–Barré syndrome, documented during outbreaks investigated by neurologists at Hopital la Pitié-Salpêtrière and research teams collaborating with the Institut Pasteur. Dermatological and ocular manifestations have been reported by specialists at the Scheie Eye Institute and pediatric units at Hospital das Clínicas (São Paulo).

diagnosis and laboratory testing

Diagnosis relies on molecular detection of viral RNA by reverse transcription polymerase chain reaction (RT-PCR) in serum, urine, or amniotic fluid during the acute phase, methods standardized by laboratories such as the Centers for Disease Control and Prevention and the World Health Organization. Serological assays detecting IgM and neutralizing antibodies require interpretation for cross-reactivity with related flaviviruses including Dengue fever; reference laboratories at the Pasteur Institute and National Institutes of Health have developed plaque reduction neutralization tests to discriminate responses. Advanced genomic sequencing and metagenomic approaches performed at centers like the Broad Institute and Wellcome Sanger Institute enable lineage tracing and outbreak investigation.

treatment, prevention, and control

There is no specific antiviral therapy approved; management is supportive as outlined by clinical guidelines from the World Health Organization, Pan American Health Organization, and specialty societies such as the Infectious Diseases Society of America. Vector control strategies implemented by municipal health departments, exemplified by programs in Miami and Rio de Janeiro, include source reduction, insecticide application, and community engagement modeled after campaigns by the Bill & Melinda Gates Foundation. Vaccine development has advanced through trials coordinated by institutions like National Institute of Allergy and Infectious Diseases, Sanofi Pasteur, and GlaxoSmithKline, with platforms ranging from inactivated vaccines to live-attenuated and DNA candidates. Recommendations on sexual transmission risk reduction were issued by national agencies including the Centers for Disease Control and Prevention and Public Health England.

epidemiology and outbreaks

Zika virus was first isolated in 1947 from a sentinel rhesus macaque in the Zika Forest near Entebbe, with subsequent serosurveys by researchers at Makerere University documenting human exposure in Africa. Large outbreaks occurred in the Pacific islands, notably on Yap Island in 2007 and in French Polynesia in 2013–2014, investigated by teams from the World Health Organization and Institut Pasteur. The virus expanded into the Americas with a major epidemic from 2015–2016 centered in Brazil and affecting countries across South America, Central America, and the Caribbean; public health responses involved coordination by the Pan American Health Organization and national ministries of health. Surveillance efforts and modeling by groups at Imperial College London, Columbia University, and the University of Oxford have tracked spread relative to Aedes mosquito distributions, climate variables, and travel patterns monitored by agencies such as International Air Transport Association.

Category:Flaviviruses